Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 96 results for "ranbaxy lab"

Religare Enterprises to split into three independent listed units

MUMBAI: Religare Enterprises, the company majority owned by the family that once were the promoters of Ranbaxy Labs, on Friday decided to split into three independent listed entities handling lending operations through the NBFC arm, running the ... Times of India, 2 months ago

1 images for "ranbaxy lab"

Money Control, 5 months ago

Sun Pharma selling off two more US facilities

Dive Brief: As part of its integration of Ranbaxy Labs, which Sun Pharma acquired last year, the largest pharma company in India is selling two US-based locations. The facilities. located in Philadelphia and Aurora, IL,are being sold to Frontida ...
 BioPharma Dive1 month ago Net sales of 100 top pharma cos move up by 10.3% to Rs. 1.9 lakh crore in 2015-16  PharmaBiz3 weeks ago Why pharma companies sell sub-standard stuff in India  Rediff.com2 months ago

Suven Life gets patent and other top pharma news

Kalyanasundaram Subramanian, or Kal Sundaram, an old hand at Sun Pharmaceutical Industries, is coming back home. He will be leading the India and sub-continent business starting January 2017. Pharmaceutical company Suven Life Sciences has been ...
 India Infoline2 weeks ago

It's imperative to have a strong IT backbone and leve..

Meet Ajit Manocha, SVP & CIO of Syngene International , a leading India-based CRO, offering a suite of integrated, end-to-end discovery, development and manufacturing services for novel molecular entities across industrial sectors including ...
 TechGig3 weeks ago

Antibacterial Drugs: World Industry and Market Prospects 2016-2026

Comments LONDON, April 12, 2016 /PRNewswire/ -- Antibacterial Drugs: World Industry and Market Prospects 2016-2026 - our new study reveals trends, R&D progress, and predicted revenues Where is the Antibacterial Drugs market heading? Visiongain's ...
 AndhraNews.net3 weeks ago New report shares details about the Global Finasteride Tablets Market Professional Survey Report 2016  Before It's News1 month ago Global Respiratory Drugs Market Overviews To Expands At 6.48% CAGR From 2016 To 2020 Stimulated By Rising Environmental Pollution  MyNewsDesk1 month ago Global Respiratory Drugs Market Expands at 6.48% CAGR from 2016 to 2020 Stimulated by Rising Environmental Pollution  MyNewsDesk1 month ago
[x]  

USFDA nods to Indian drugs up 84% in 1 year

MUMBAI: Drug approvals given by the US Food and Drug Administration (USFDA) to Indian companies nearly doubled year-on-year, with littleknown firms including MSN Lab, Shasun Pharma, Granules India, Ajanta Pharma and Gland Pharma making a foray into ...
 Economic Times4 weeks ago USFDA nods to desi drugs up 84% in 1 year  Times of India3 weeks ago

Fracas at pharma firm's meeting to discuss transfers

Nagpur: A meeting called by Sun Pharma to discuss transfer issues of employees took an ugly turn when field workers and the management entered into a tiff at a city hotel on Wardha Road on Saturday. The fracas forced the hotel management seek police ...
 Times of India1 month ago
International Business Times India

Allowing 74% FDI in pharma sector may attract many MNCs to invest in India

The new Foreign Direct Investment (FDI) policy 2016 allowing 74 per cent FDI through automatic route in pharmaceutical industry will open up the foreign investments in pharma industry as many foreign companies are looking for an investment in ...
 PharmaBiz1 month ago Govt's pharma FDI sop may hit affordable healthcare  Financial Express1 month ago Jaitley proposes to allow direct FDI in pharma sector; domestic companies worry over M&As  International Business Times India1 month ago

FDI up to 74% in brownfield pharma under automatic route

The government today allowed up to 74 per cent foreign direct investment in the existing pharmaceutical companies through automatic route, with an aim to promote the sector. Earlier, 100 per cent FDI was permitted through government approval route.
 Moneycontrol.com1 month ago
[x]  

Pharma M&As: value creator or value destroyer?

Anil Khanna , Partner, Tai Pi Advisors analyses the trend of rising M&As in the pharma industry and examines its causes and implications Anil Khanna What is it with M&As that they make the adrenalin skyrocket, or generate a strong urge to go ...
 Financial Express1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less